# Clinical Evaluation of a Vascular Venous Anastomotic Connector \[InterGraft VIG-only Study\]

Study · id `cardio:ct-nct02532621` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02532621](<https://clinicaltrials.gov/study/NCT02532621>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02532621

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.

## Technical summary

Registry record NCT02532621. Allocation not applicable; no masking; primary purpose treatment. Start 2018-02-21 (actual); primary completion 2022-01-19 (actual). Results posted on 2025-01-01.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 158 participants (enrolled count; ClinicalTrials.gov record NCT02532621, source copy `cardio:ctgov-nct02532621-2025-02-06`, retrieved 2026-10-26)
- Started: 2018-02-21 (actual) (ClinicalTrials.gov record NCT02532621, source copy `cardio:ctgov-nct02532621-2025-02-06`, retrieved 2026-10-26)
- Primary completion: 2022-01-19 (actual) (ClinicalTrials.gov record NCT02532621, source copy `cardio:ctgov-nct02532621-2025-02-06`, retrieved 2026-10-26)
- Completion: 2022-01-19 (actual) (ClinicalTrials.gov record NCT02532621, source copy `cardio:ctgov-nct02532621-2025-02-06`, retrieved 2026-10-26)
- Results first posted: 2025-01-01 (ClinicalTrials.gov record NCT02532621, source copy `cardio:ctgov-nct02532621-2025-02-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02532621, source copy `cardio:ctgov-nct02532621-2025-02-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02532621-2025-02-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Evaluation of a Vascular Venous Anastomotic Connector \[InterGraft VIG-only Study\]
- Condition: End Stage Renal Disease
- Intervention (Device): Venous InterGraft Connector
- Intervention (Procedure): sutured arterial anastomosis of an implanted vascular graft for hemodialysis
- Intervention (Procedure): hemodialysis
- Lead sponsor: Phraxis, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 77a6340d74cf07d0b342dfdb974612cc564218e0dc8a5bb03351c521b621e269
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
